Correlation Between Elysee Development and Big Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elysee Development and Big Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elysee Development and Big Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elysee Development Corp and Big Pharma Split, you can compare the effects of market volatilities on Elysee Development and Big Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elysee Development with a short position of Big Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elysee Development and Big Pharma.

Diversification Opportunities for Elysee Development and Big Pharma

0.27
  Correlation Coefficient

Modest diversification

The 3 months correlation between Elysee and Big is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Elysee Development Corp and Big Pharma Split in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Big Pharma Split and Elysee Development is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elysee Development Corp are associated (or correlated) with Big Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Big Pharma Split has no effect on the direction of Elysee Development i.e., Elysee Development and Big Pharma go up and down completely randomly.

Pair Corralation between Elysee Development and Big Pharma

Assuming the 90 days horizon Elysee Development Corp is expected to generate 1.75 times more return on investment than Big Pharma. However, Elysee Development is 1.75 times more volatile than Big Pharma Split. It trades about 0.06 of its potential returns per unit of risk. Big Pharma Split is currently generating about 0.1 per unit of risk. If you would invest  47.00  in Elysee Development Corp on October 5, 2025 and sell it today you would earn a total of  4.00  from holding Elysee Development Corp or generate 8.51% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Elysee Development Corp  vs.  Big Pharma Split

 Performance 
       Timeline  
Elysee Development Corp 

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Elysee Development Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Elysee Development may actually be approaching a critical reversion point that can send shares even higher in February 2026.
Big Pharma Split 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Big Pharma Split are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating primary indicators, Big Pharma may actually be approaching a critical reversion point that can send shares even higher in February 2026.

Elysee Development and Big Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elysee Development and Big Pharma

The main advantage of trading using opposite Elysee Development and Big Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elysee Development position performs unexpectedly, Big Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Big Pharma will offset losses from the drop in Big Pharma's long position.
The idea behind Elysee Development Corp and Big Pharma Split pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Stocks Directory
Find actively traded stocks across global markets